Tessera

Lymphoma and Related Diseases Registry

@lardr.bsky.social

Australian & New Zealand real-world data to improve patient care and clinical outcomes for lymphomas and related diseases. Visit us at lardr.org

17 Posts39 Follower 53 Folgt

⭐️⭐️⭐️ The 10000th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry! Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.

Congrats to our consumer representative, Ms Janne Williams👏 She was awarded the SPHPM Consumer Excellence Award🌟 in recognition of her impact on multiple academic projects, including LaRDR! @ericawood.bsky.social #LymphomaResearch #Registry

Congratulations to Ms Janne Williams, recipient of the SPHPM Consumer Excellence Award

lardr.org

@lardr.bsky.social is co-hosting a breakfast meeting on Tuesday, 28 October, at 7 am AWST with the Australasian Lymphoma Alliance & Lymphoma Australia! Walk-ins to room M1 at the Perth Convention & Exhibition Centre and online attendance (link below) are welcome! us06web.zoom.us/w/8786927032...

Join our Cloud HD Video Meeting

Zoom is the leader in modern enterprise cloud communications.

us06web.zoom.us

Our registry bulk study has been interviewed by Oncology Republic 📰 'Lymphoma bulk: why size doesn’t always matter' @elizahawkes.bsky.social @ericawood.bsky.social @allibarraclough.bsky.social #Registry #LymphomaResearch #ClinicalResearch

Lymphoma bulk: why size doesn’t always matter - Oncology Republic

Tumour bulk shouldn't be relied on as a marker of prognosis, Australian researchers say.

oncologyrepublic.com.au

⭐️⭐️⭐️ The 9500th participant ⭐️⭐️⭐️was recruited to the Lymphoma and Related Diseases Registry! Congratulations and thanks to all participants, participating sites and staff, principal investigators and supporters.

📣 Register now for the hybrid Lymphoma Breakfast Meeting! Join us online to hear updates on our work, presented alongside the Australian Lymphoma Alliance and Lymphoma Australia. 🥐☕ Breakfast will be provided for on-site attendees.

ALA/LaRDR/LA Lymphoma Breakfast Meeting

Please join us for breakfast during BLOOD 2025

eventbrite.com.au

We're also showcasing our #18ICML posters: -221, real-world data on end-of-treatment imaging #TCellLymphoma; -390, Ki67 expression level in #FollicularLymphoma See you June 18👋 @icmlugano.bsky.social @ericawood.bsky.social @elizahawkes.bsky.social #LymphomaResearch #ClinicalResearch #Registry

END‐OF‐TREATMENT PET/CT COMPLETE REMISSION IS HIGHLY PROGNOSTIC IN NODAL PERIPHERAL T‐CELL LYMPHOMA: AN AUSTRALASIAN‐CANADIAN COLLABORATIVE STUDY

Click on the article title to read more.

doi.org

Thanks to all who stopped by to chat with us at our #FollicularLymphoma #EHA2025 poster 👋 @hemasphere-journal.bsky.social @ericawood.bsky.social @elizahawkes.bsky.social #LymphomaResearch #ClinicalResearch #Registry

LaRDR at EHA conference 2025!

lardr.org

We're excited to meet you at our #EHA2025 poster PS1885 to talk about the study of Ki67 expression in Australasian #FollicularLymphoma patients. See you Saturday, June 14 👋 @hemasphere-journal.bsky.social @ericawood.bsky.social @elizahawkes.bsky.social #LymphomaResearch #ClinicalResearch #Registry

DETERMINING THE PROGNOSTIC SIGNIFICANCE OF THE KI67 PROLIFERATION... by Eliza Chung

EHA Library; Chung E. Jun 14 2025; 4160959;

library.ehaweb.org

Catch up on our latest newsletter 📰 sway.cloud.microsoft/TCxuAWeWloXztORw?ref=Link For our previous news and updates, visit lardr.org/newsletter

Lymphoma and Related Diseases Registry Newsletter: June 2025

Welcome to the LaRDR newsletter.

sway.cloud.microsoft

The Lymphoma and Related Diseases Registry enrolled the ⭐9000th⭐ participant on May 8, 2025! We would like to express our sincere gratitude to all participants, participating sites and staff, principal investigators and industry partners for their continued support of the registry 🙌

LaRDR provides #research 🔍 opportunities for #lymphoma & #CLL investigators and fellows in regional/rural hospitals🏥across Australia and New Zealand 🌏 Tune in to this interview to hear more from Dr Wight! 🎬 youtu.be/3csUYJsZkZs